Tarlatamab-Dlle. 1 mg, 10 mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 1 mg, 10 mg
Reference Brands: Imdelltra (USA), Imdylltra (EU/UK)
Category: Oncology Cancer Care
Tarlatamab-dlle is a bispecific T-cell engager (BiTE) antibody that binds DLL3 on small cell lung cancer cells and CD3 on T cells, enabling targeted immune killing of tumor cells. It is approved for adults with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. It has shown meaningful response rates and durable clinical benefit in resistant disease. The treatment is given by step-up intravenous infusion to reduce the risk of cytokine release syndrome. Patients are monitored closely for immune-related reactions and neurological side effects.
Tarlatamab-Dlle. — third party manufacturing & bulk supply
Tarlatamab-Dlle. 1 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Tarlatamab-Dlle. is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Tarlatamab-Dlle. listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Tarlatamab-Dlle. →Frequently Asked Questions
Tarlatamab-dlle is used for the treatment of extensive-stage small cell lung cancer (ES-SCLC) in adults who have disease progression after platinum-based chemotherapy.
It is made from a bispecific T-cell engager (BiTE) antibody construct that binds to DLL3 on tumor cells and CD3 on T-cells to trigger targeted immune-mediated killing.
The trade name is Imdelltra.
It is manufactured and marketed by Amgen Inc.
The generic name is tarlatamab-dlle.
The brand name is Imdelltra.
It is manufactured by Amgen at its biologics production facilities in the United States.
Related Products
Decitabine + Cedazuridine
Strength:
35 mg + 100mg
Form: Tablets
Reference Brands: Inqovi (USA/EU)
View Details
Ponatinib Hydrochloride
Strength:
10 mg, 15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Iclusig (USA)
View Details
Idarubicin Hydrochloride
Strength:
5 mg/5 mL
Form: Injection
Reference Brands: Idamycin (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
